Autoantibodies and Clinical Symptoms in Infective Endocarditis Patients

Study of Autoantibodies in Infective Endocarditis

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00562653

Enrollment

100

Registered

2007-11-22

Start date

2007-11-30

Completion date

2008-11-30

Last updated

2007-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infective Endocarditis

Keywords

profile autoantibodies, clinical symptoms

Brief summary

The purpose is to evaluate autoantibodies in infective endocarditis patients before, at the beginning of treatment, and after the end of the treatment, and to correlate the autoantibodies in the presence of clinical symptoms.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Infective endocarditis patients by DUKES criteria

Exclusion criteria

* HIV positive * Patients suffering from other infective diseases other than endocarditis. * Patient suffering from collagen diseases for example: systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), mixed connective tissue disease, and scleroderma.

Countries

Israel

Outcome results